Título : The Effects of Nicotine on Cortical Excitability After Exercise: A Double-Blind Randomized, Placebo-controlled, Crossover Study. |
Autor : Zandonai, Thomas  Pizzolato, Fabio  TAM, Enrico  BRUSEGHINI, Paolo  Chiamulera, Cristiano  Cesari, Paola  |
Editor : Lippincott, Williams & Wilkins |
Departamento: Departamentos de la UMH::Farmacología, Pediatría y Química Orgánica |
Fecha de publicación: 2020 |
URI : https://hdl.handle.net/11000/40662 |
Resumen :
Purpose: The use of smokeless tobacco/nicotine products is common
among athletes, but clear evidence for their positive or negative effect on
sports performance is lacking. Nicotine is a psychoactive substance involved
in numerous neuronal processes including cortical excitability. The aim of
this study was to evaluate its effect on cortical excitability associated with
aerobic exercise in nicotine-naive healthy volunteers.
Methods: Ten nicotine-naive healthy volunteers were recruited for this
double-blind, randomized, crossover study to compare the effect of snus
(8 mg nicotine), an oral, smokeless tobacco product, to placebo on cortical
excitability before and after aerobic exercise. Transcranial magnetic stimulation
(TMS) was used to measure changes in corticomotor excitability
(motor-evoked potentials, MEPs) and electromyography of leg muscles
duringmaximal voluntary contractions (MVC) to assess changes inmuscle
contractions. Before and after aerobic exercise and with or without nicotine
treatment, MEPs and MVCs were measured.
Results: Analysis of TMS data showed lower motor cortex activation
(lower MEP amplitude) after snus administration compared with placebo,
whereas electromyography data showed no difference in muscle contraction
between snus and placebo treatment.
Conclusions: These findings suggest a general reduction in cortical excitability,
without no relevant effect on physical performance.
|
Palabras clave/Materias: nicotine smokeless tobacco cortical excitability exercise TMS |
Área de conocimiento : CDU: Ciencias aplicadas: Medicina |
Tipo de documento : info:eu-repo/semantics/article |
Derechos de acceso: info:eu-repo/semantics/closedAccess Attribution-NonCommercial-NoDerivatives 4.0 Internacional |
DOI : 10.1097/jcp.0000000000001246 |
Publicado en: Journal of Clinical Psychopharmacology, 40(5), 495-498 - July 2020 |
Aparece en las colecciones: Artículos - Farmacología, Pediatría y Química Orgánica
|